FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014724962> ?p ?o ?g. }

• W2014724962 endingPage "1607" @default.
• W2014724962 startingPage "1599" @default.
• W2014724962 abstract "Cardiac dysfunction, particularly QT interval prolongation, has been observed with tyrosine kinase inhibitors approved to treat chronic myeloid leukemia. This study examines the effects of ponatinib on cardiac repolarization in patients with refractory hematological malignancies enrolled in a phase 1 trial. Electrocardiograms (ECGs) were collected at 3 dose levels (30, 45, and 60 mg) at 6 time points. Electrocardiographic parameters, including QTc interval, were measured, and 11 morphological analyses were conducted. Central tendency analyses of ECG parameters were performed using time-point and time-averaged approaches. All patients with at least 2 baseline ECGs and 1 on-treatment ECG were included in the analyses. Patients with paired ECGs and plasma samples were included in the pharmacokinetic/pharmacodynamic analysis to examine the relationship between ponatinib plasma concentration and change from baseline in QT intervals. Thirty-nine patients at the 30-, 45-, and 60-mg dose levels were included in the central tendency and morphological analyses. There was no significant effect on cardiac repolarization, as evidenced by non-clinically significant mean QTcF changes from baseline of −10.9, −3.6, and −5.0 ms for the 30-, 45-, and 60-mg dose levels, respectively. The morphological analysis revealed 2 patients with atrial fibrillation and 2 with T wave inversion. Seventy-five patients were included in the pharmacokinetic/pharmacodynamic analysis across all dose levels. The slope of the relationship for QTcF versus plasma ponatinib concentration was not positive (−0.0171), indicating no exposure–effect relationship. Ponatinib is associated with a low risk of QTc prolongation in patients with refractory hematological malignancies." @default.
• W2014724962 created "2016-06-24" @default.
• W2014724962 creator A5011529063 @default.
• W2014724962 creator A5011559739 @default.
• W2014724962 creator A5013996692 @default.
• W2014724962 creator A5015115182 @default.
• W2014724962 creator A5015140142 @default.
• W2014724962 creator A5015789771 @default.
• W2014724962 creator A5022765643 @default.
• W2014724962 creator A5039812614 @default.
• W2014724962 creator A5041829729 @default.
• W2014724962 creator A5048784887 @default.
• W2014724962 creator A5084436319 @default.
• W2014724962 creator A5085532403 @default.
• W2014724962 creator A5090435894 @default.
• W2014724962 date "2013-04-23" @default.
• W2014724962 modified "2023-09-27" @default.
• W2014724962 title "Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies" @default.
• W2014724962 cites W1965429870 @default.
• W2014724962 cites W1993675254 @default.
• W2014724962 cites W1998990808 @default.
• W2014724962 cites W2028959752 @default.
• W2014724962 cites W2038830184 @default.
• W2014724962 cites W2054251966 @default.
• W2014724962 cites W2097799776 @default.
• W2014724962 cites W2100897424 @default.
• W2014724962 cites W2104694028 @default.
• W2014724962 cites W2107268345 @default.
• W2014724962 cites W2110648386 @default.
• W2014724962 cites W2136065656 @default.
• W2014724962 cites W2344087471 @default.
• W2014724962 cites W2560510265 @default.
• W2014724962 cites W2566863760 @default.
• W2014724962 doi "https://doi.org/10.1007/s00280-013-2160-7" @default.
• W2014724962 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3668123" @default.
• W2014724962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23609479" @default.
• W2014724962 hasPublicationYear "2013" @default.
• W2014724962 type Work @default.
• W2014724962 sameAs 2014724962 @default.
• W2014724962 citedByCount "24" @default.
• W2014724962 countsByYear W20147249622013 @default.
• W2014724962 countsByYear W20147249622014 @default.
• W2014724962 countsByYear W20147249622016 @default.
• W2014724962 countsByYear W20147249622017 @default.
• W2014724962 countsByYear W20147249622018 @default.
• W2014724962 countsByYear W20147249622019 @default.
• W2014724962 countsByYear W20147249622020 @default.
• W2014724962 countsByYear W20147249622021 @default.
• W2014724962 countsByYear W20147249622022 @default.
• W2014724962 countsByYear W20147249622023 @default.
• W2014724962 crossrefType "journal-article" @default.
• W2014724962 hasAuthorship W2014724962A5011529063 @default.
• W2014724962 hasAuthorship W2014724962A5011559739 @default.
• W2014724962 hasAuthorship W2014724962A5013996692 @default.
• W2014724962 hasAuthorship W2014724962A5015115182 @default.
• W2014724962 hasAuthorship W2014724962A5015140142 @default.
• W2014724962 hasAuthorship W2014724962A5015789771 @default.
• W2014724962 hasAuthorship W2014724962A5022765643 @default.
• W2014724962 hasAuthorship W2014724962A5039812614 @default.
• W2014724962 hasAuthorship W2014724962A5041829729 @default.
• W2014724962 hasAuthorship W2014724962A5048784887 @default.
• W2014724962 hasAuthorship W2014724962A5084436319 @default.
• W2014724962 hasAuthorship W2014724962A5085532403 @default.
• W2014724962 hasAuthorship W2014724962A5090435894 @default.
• W2014724962 hasBestOaLocation W20147249621 @default.
• W2014724962 hasConcept C111113717 @default.
• W2014724962 hasConcept C112705442 @default.
• W2014724962 hasConcept C118441451 @default.
• W2014724962 hasConcept C121332964 @default.
• W2014724962 hasConcept C126322002 @default.
• W2014724962 hasConcept C142424586 @default.
• W2014724962 hasConcept C146403970 @default.
• W2014724962 hasConcept C164705383 @default.
• W2014724962 hasConcept C185263204 @default.
• W2014724962 hasConcept C2777413986 @default.
• W2014724962 hasConcept C2777583451 @default.
• W2014724962 hasConcept C2778729363 @default.
• W2014724962 hasConcept C2779362680 @default.
• W2014724962 hasConcept C2780381907 @default.
• W2014724962 hasConcept C71924100 @default.
• W2014724962 hasConcept C83743174 @default.
• W2014724962 hasConcept C87355193 @default.
• W2014724962 hasConceptScore W2014724962C111113717 @default.
• W2014724962 hasConceptScore W2014724962C112705442 @default.
• W2014724962 hasConceptScore W2014724962C118441451 @default.
• W2014724962 hasConceptScore W2014724962C121332964 @default.
• W2014724962 hasConceptScore W2014724962C126322002 @default.
• W2014724962 hasConceptScore W2014724962C142424586 @default.
• W2014724962 hasConceptScore W2014724962C146403970 @default.
• W2014724962 hasConceptScore W2014724962C164705383 @default.
• W2014724962 hasConceptScore W2014724962C185263204 @default.
• W2014724962 hasConceptScore W2014724962C2777413986 @default.
• W2014724962 hasConceptScore W2014724962C2777583451 @default.
• W2014724962 hasConceptScore W2014724962C2778729363 @default.
• W2014724962 hasConceptScore W2014724962C2779362680 @default.
• W2014724962 hasConceptScore W2014724962C2780381907 @default.
• W2014724962 hasConceptScore W2014724962C71924100 @default.
• W2014724962 hasConceptScore W2014724962C83743174 @default.

• next